Mode of Sedation During Endovascular Treatment of Vertebrobasilar Stroke
MOONRISE
1 other identifier
interventional
128
1 country
1
Brief Summary
Optimal anesthetic mode is not established for patients with vertebrobasilar stroke undergoing endovascular treatment. We want to investigate whether a procedural sedation mode approach is feasible compared to general anesthesia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 23, 2022
CompletedFirst Posted
Study publicly available on registry
September 1, 2022
CompletedStudy Start
First participant enrolled
October 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2029
April 30, 2026
April 1, 2026
6.3 years
August 23, 2022
April 29, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Functional outcome as measured by modified Ranking Scale (mRS) after admission.
0-6; higher mean worse outcome
90 days +/- 2 weeks
Secondary Outcomes (5)
Early neurological improvement indicated by change of National Institute of Health Stroke Scale (NIHSS) Score 24 hours after admission
[NIHSS on admission - NIHSS after 24 hours]
Mortality
intra-hospital until discharge up to 2 weeks [yes/no] and over the whole follow-up period up to 3 months [time to event]
Postinterventional pc-ASPECTS, determined with CT or MRI post-interventional follow up scan
12-36 hours after admission
Feasibility of EST
duration of thrombectomy procedure in minutes
Complications before/during and after EST
duration of the whole hospital stay in days
Study Arms (2)
General Anesthesia Group
ACTIVE COMPARATORPatients randomized to the GA arm are intubated after anesthetic induction.
Procedural Sedation Group
EXPERIMENTALAfter randomization into the PS arm, the need for analgesics or sedatives are evaluated clinically.
Interventions
Patients randomized to the GA arm are intubated after anesthetic induction. For this purpose, they are pre-oxygenated with an oxygen mask and non-invasive monitoring is established. After sufficient pre-oxygenation has been applied, analgesic and sedative medication are administered. If the patient is sufficiently long nil by mouth they are manually ventilated before a muscle relaxant is administered. A rapid-sequence induction is performed with administration of an opioid, sedative and muscle relaxant in rapid succession and without intermediate manual ventilation in non-nil by mouth patients. To secure the airway, an endotracheal tube is inserted into the trachea with the aid of a laryngoscope. After insertion of the endotracheal tube, its endotracheal position is confirmed with auscultation and capnography. GA maintenance therapy with opioids, sedatives and catecholamines, if needed, will then be started.
Eligibility Criteria
You may qualify if:
- Decision for thrombectomy according to local protocol for acute recanalizing stroke treatment
- Age 18 years or older, either sex
- National Institutes of Health Stroke Scale (NIHSS) ≥ 4
- Acute ischemic stroke in the posterior circulation with isolated or combined occlusion of vertebral artery (VA) and basilar artery (BA)
- Informed consent by the patient him-/herself or his/her legal representative obtainable within 72 h of treatment (deferred consenting procedure)
You may not qualify if:
- Intracerebral hemorrhage
- Coma on admission (Glasgow Coma Scale ≤ 8)
- Severe respiratory instability, loss of airway protective reflexes or vomiting on admission, where primary intubation and general anesthesia is deemed necessary
- Intubated state before randomization
- Severe hemodynamic instability (e.g. due to decompensated cardiac insufficiency)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Neurology, University Hospital Heidelberg
Heidelberg, Baden-Wurttemberg, 69120, Germany
Related Publications (3)
Jadhav AP, Bouslama M, Aghaebrahim A, Rebello LC, Starr MT, Haussen DC, Ranginani M, Whalin MK, Jovin TG, Nogueira RG. Monitored Anesthesia Care vs Intubation for Vertebrobasilar Stroke Endovascular Therapy. JAMA Neurol. 2017 Jun 1;74(6):704-709. doi: 10.1001/jamaneurol.2017.0192.
PMID: 28395002BACKGROUNDWeyland CS, Chen M, Potreck A, Jager LB, Seker F, Schonenberger S, Bendszus M, Mohlenbruch M. Sedation Mode During Endovascular Stroke Treatment in the Posterior Circulation-Is Conscious Sedation for Eligible Patients Feasible? Front Neurol. 2021 Sep 17;12:711558. doi: 10.3389/fneur.2021.711558. eCollection 2021.
PMID: 34603184BACKGROUNDSchonenberger S, Henden PL, Simonsen CZ, Uhlmann L, Klose C, Pfaff JAR, Yoo AJ, Sorensen LH, Ringleb PA, Wick W, Kieser M, Mohlenbruch MA, Rasmussen M, Rentzos A, Bosel J. Association of General Anesthesia vs Procedural Sedation With Functional Outcome Among Patients With Acute Ischemic Stroke Undergoing Thrombectomy: A Systematic Review and Meta-analysis. JAMA. 2019 Oct 1;322(13):1283-1293. doi: 10.1001/jama.2019.11455.
PMID: 31573636RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Silvia Schönenberger, MD
University Hospital Heidelberg
- PRINCIPAL INVESTIGATOR
Min Chen, MD
UUHeidelberg
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Section of Neurointensive Care
Study Record Dates
First Submitted
August 23, 2022
First Posted
September 1, 2022
Study Start
October 1, 2022
Primary Completion (Estimated)
January 1, 2029
Study Completion (Estimated)
January 1, 2029
Last Updated
April 30, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share